PI-LAB-2025-046

PT-141, Independent Lab Report

PT-141 10mg · BioRegen Research

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 98.7% met the stated ≥99% claim. Content measured 99.1% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
98.7%

Label claimed ≥99%

Content accuracy
99.1%

9.91mg measured against 10mg claimed

Test recency
Older result

Published 14 months ago

Specimen PI-LAB-2025-046 Tested by Vantage Analytical Labs 17 samples tested from this company Purity & Testing score 99/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 99% 98.7% Within analytical tolerance
Identity (MS) PT-141 Confirmed Matches label
Content 10 mg 9.91 mg Within 5% of label

Methodology & chain of custody

Quantitative amino acid analysis against certified reference standard.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Vantage Analytical Labs. See our full testing methodology.

Lot / batch
R4099-25
Purchased
Analysed
Published
Laboratory
Vantage Analytical Labs
Test type
Full panel (purity, identity, content, endotoxin)

Original laboratory report: PI-LAB-2025-046-report.pdf (document delivery arrives with the production storage backend)

More Tests, BioRegen Research

Tirzepatide (Compounded)
Purity 99.0% Verified
TB-500
Purity 99.2% Verified
CJC-1295
Purity 98.6% Verified

More Tests, PT-141

PT-141 NextGen Peptides
Purity 98.5% Verified
PT-141 BioRegen Research
Purity 95.1% Verified
PT-141 Helix Research Supply
Purity 97.6% Discrepancy